Skip to main content
  • Main menu
  • User menu
  • Search
  • English ▼
    • English
    • Afrikaans
    • Albanian
    • Amharic
    • Arabic
    • Armenian
    • Azerbaijani
    • Basque
    • Belarusian
    • Bengali
    • Bosnian
    • Bulgarian
    • Catalan
    • Cebuano
    • Chichewa
    • Chinese (Simplified)
    • Chinese (Traditional)
    • Corsican
    • Croatian
    • Czech
    • Danish
    • Dutch
    • Esperanto
    • Estonian
    • Filipino
    • Finnish
    • French
    • Frisian
    • Galician
    • Georgian
    • German
    • Greek
    • Gujarati
    • Haitian Creole
    • Hausa
    • Hawaiian
    • Hebrew
    • Hindi
    • Hmong
    • Hungarian
    • Icelandic
    • Igbo
    • Indonesian
    • Irish
    • Italian
    • Japanese
    • Javanese
    • Kannada
    • Kazakh
    • Khmer
    • Korean
    • Kurdish (Kurmanji)
    • Kyrgyz
    • Lao
    • Latin
    • Latvian
    • Lithuanian
    • Luxembourgish
    • Macedonian
    • Malagasy
    • Malay
    • Malayalam
    • Maltese
    • Maori
    • Marathi
    • Mongolian
    • Myanmar (Burmese)
    • Nepali
    • Norwegian
    • Pashto
    • Persian
    • Polish
    • Portuguese
    • Punjabi
    • Romanian
    • Russian
    • Samoan
    • Scottish Gaelic
    • Serbian
    • Sesotho
    • Shona
    • Sindhi
    • Sinhala
    • Slovak
    • Slovenian
    • Somali
    • Spanish
    • Sudanese
    • Swahili
    • Swedish
    • Tajik
    • Tamil
    • Telugu
    • Thai
    • Turkish
    • Ukrainian
    • Urdu
    • Uzbek
    • Vietnamese
    • Welsh
    • Xhosa
    • Yiddish
    • Yoruba
    • Zulu

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

English ▼
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scottish Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sudanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu
  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Review ArticleTeaching Case Studies

Bisphosphonate-Associated Atypical Subtrochanteric Femur Fracture

Ely A. Wolin, Kevin P. Banks and Penny J. Vroman
Journal of Nuclear Medicine Technology March 2015, 43 (1) 72-73; DOI: https://doi.org/10.2967/jnmt.114.139923
Ely A. Wolin
Department of Radiology, San Antonio Military Medical Center, Fort Sam Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin P. Banks
Department of Radiology, San Antonio Military Medical Center, Fort Sam Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Penny J. Vroman
Department of Radiology, San Antonio Military Medical Center, Fort Sam Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Bisphosphonates help prevent progressive bone mineralization loss and subsequent osteoporotic fractures. However, long-term bisphosphonate therapy paradoxically increases the risk of a unique injury called an atypical subtrochanteric femur fracture. Despite this, the benefits of bisphosphonates outweigh the risks, because far more pathologic fractures are prevented than induced. The early identification of atypical subtrochanteric femur fractures is important as there is high associated morbidity and mortality. We describe a case of a 76-y-old woman with a completed bisphosphonate-associated atypical subtrochanteric femur fracture.

  • bisphosphonate
  • osteoporosis
  • atypical subtrochanteric femoral fracture

Long-term bisphosphonate therapy is associated with an increased risk of atypical femoral fractures. Early identification and intervention is essential to avoid the associated morbidity and mortality of a completed fracture.

CASE REPORT

A 76-y-old woman presented with severe, atraumatic, right hip and thigh pain. She reported a history of osteopenia treated with bisphosphonates (nearly 4 y of alendronate, followed by 4 y of ibandronate). Femur radiographs at presentation were read as normal but on retrospect demonstrated focal cortical thickening along the lateral diaphysis (Fig. 1). A bone scan 5 d later showed focal radiotracer uptake at the same site, interpreted as concerning for an atypical subtrochanteric femur fracture (Fig. 2). Six days later, the patient re-presented with increasing pain after a fall from standing. Repeated radiographs showed a displaced transverse fracture through the proximal right femoral diaphysis (Fig. 3).

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

Small focal area of cortical thickening (arrow) along lateral cortex of proximal right femoral diaphysis.

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

Anterior (A) and posterior (B) images from 99mTc-labeled methyl diphosphonate bone scan demonstrating focal intense increased radiotracer uptake along lateral cortex of proximal right femoral diaphysis.

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

Markedly displaced transverse fracture of proximal right femoral diaphysis with bayoneting.

DISCUSSION

Osteoporosis places individuals at high risk for insufficiency and fragility fractures. Treatment includes lifestyle modifications and pharmacologic intervention, frequently with bisphosphonates (1).

Bisphosphonates work by inducing osteoclast apoptosis (2,3). A known risk of long-term bisphosphonate therapy is a unique fracture known as an atypical subtrochanteric femur fracture. These may result from impaired remodeling allowing microfractures to progress (4). A 2008 study of the entire population of Sweden reported an age-adjusted relative risk of atypical femur fracture with any bisphosphonate use of 47.3, corresponding to an additional 5 cases per 10,000 patient-years (5). Multiple additional epidemiologic studies showed a patient on bisphosphonates had a relative risk of atypical femur fracture ranging from 2.11 to 66.9, although the absolute risk remains low (4). These fractures have a mortality rate of 14% at 12 mo and 25% at 24 mo (6).

The American Society for Bone and Mineral Research task force recommended a fracture must be located distal to the lesser trochanter to just proximal to the supracondylar flare and have 4 of these 5 major features to be classified as atypical: (1) no or minimal associated trauma, as in a fall from standing; (2) the fracture line originating at the lateral cortex, substantially transverse in its orientation; (3) complete fractures involving both cortices (may be associated with a medial spike) or incomplete fractures involving only the lateral cortex; (4) noncomminuted or minimally comminuted; and (5) localized periosteal or endosteal thickening of the lateral cortex is present (4). On bone scanning, there will be focal increased radiotracer activity corresponding to the area of cortical thickening (7).

Early diagnosis of incomplete fractures helps prevent completion by allowing for prophylactic operative management (4).

CONCLUSION

Although bisphosphonate therapy prevents far more osteoporotic fractures than it induces atypical fractures, atypical subtrochanteric fractures have high morbidity and mortality. Thus, early recognition is necessary to allow for appropriate protective operative intervention.

DISCLOSURE

No potential conflict of interest relevant to this article was reported.

Footnotes

  • Published online Aug. 14, 2014.

REFERENCES

  1. 1.↵
    1. Rosen HN,
    2. Drezner MK
    . Overview of the management of osteoporosis in postmenopausal women. UpToDate. http://www.uptodate.com/contents/overview-of-the-management-of-osteoporosis-in-postmenopausal-women. Updated January 24, 2014. Accessed July 11, 2014.
    Google Scholar
  2. 2.↵
    1. Rosen HN
    . The use of bisphosphonates in postmenopausal women with osteoporosis. UpToDate. http://www.uptodate.com/contents/the-use-of-bisphosphonates-in-postmenopausal-women-with-osteoporosis. Updated September 19, 2013. Accessed July 11, 2014.
    Google Scholar
  3. 3.↵
    1. Chan SS,
    2. Rosenberg ZS,
    3. Chan K,
    4. Capeci C
    . Subtrochanteric femoral fractures in patients receiving long-term alendronate therapy: imaging features. AJR. 2010;194:1581–1586.
    OpenUrlCrossRefPubMedGoogle Scholar
  4. 4.↵
    1. Shane E,
    2. Burr D,
    3. Abrahamsen B,
    4. et al
    . Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2014;29:1–23.
    OpenUrlCrossRefPubMedGoogle Scholar
  5. 5.↵
    1. Schilcher J,
    2. Michaelsson K,
    3. Aspenberg P
    . Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med. 2011;364:1728–1737.
    OpenUrlCrossRefPubMedGoogle Scholar
  6. 6.↵
    1. Ekström W,
    2. Nemeth G,
    3. Smnegard E,
    4. Dalen N,
    5. Tidermark J
    . Quality of life after a subtrochanteric fracture: a prospective cohort study on 87 elderly patients. Injury. 2009;40:371–376.
    OpenUrlCrossRefPubMedGoogle Scholar
  7. 7.↵
    1. Probst S,
    2. Rakheja R,
    3. Stern J
    . Aytpical bisphosphonate-associated subtrochanteric and femoral shaft stress fractures. Clin Nucl Med. 2013;38:397–399.
    OpenUrlCrossRefPubMedGoogle Scholar
  • Received for publication March 7, 2014.
  • Accepted for publication April 28, 2014.
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 43 (1)
Journal of Nuclear Medicine Technology
Vol. 43, Issue 1
March 1, 2015
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Email Article
Citation Tools
Share
Bisphosphonate-Associated Atypical Subtrochanteric Femur Fracture
Ely A. Wolin, Kevin P. Banks, Penny J. Vroman
Journal of Nuclear Medicine Technology Mar 2015, 43 (1) 72-73; DOI: 10.2967/jnmt.114.139923
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
Bookmark this article

Jump to section

  • Article
    • Abstract
    • CASE REPORT
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • High-Sensitivity Troponin Elevation in a Young Woman with Typical Chest Pain: The Heart of the Matter
  • Pulmonary Adenocarcinoma Revealed by Parathyroid Scintigraphy: An Incidental Case to Remember
  • Prominent Right Ventricular Tracer Uptake: A Harbinger of Multivessel Coronary Artery Disease
Show more Teaching Case Studies

Similar Articles

Keywords

  • bisphosphonate
  • osteoporosis
  • atypical subtrochanteric femoral fracture
SNMMI

© 2025 SNMMI

Powered by HighWire
Alerts for this Article
Sign In to Email Alerts with your Email Address
Email this Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Bisphosphonate-Associated Atypical Subtrochanteric Femur Fracture
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Bisphosphonate-Associated Atypical Subtrochanteric Femur Fracture
Ely A. Wolin, Kevin P. Banks, Penny J. Vroman
Journal of Nuclear Medicine Technology Mar 2015, 43 (1) 72-73; DOI: 10.2967/jnmt.114.139923

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

We use cookies on this site to enhance your user experience

By clicking any link on this page you are giving your consent for us to set cookies.